Stay updated on Study of ARO-HSD in NASH Clinical Trial
Sign up to get notified when there's something new on the Study of ARO-HSD in NASH Clinical Trial page.

Latest updates to the Study of ARO-HSD in NASH Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov release label changes from v3.7.0 to v3.7.1. The study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAccess to the study record now returns a 403 Forbidden page, replacing the expected study details with a site error message. This indicates an access issue rather than a substantive update to the study information.SummaryDifference20%

- Check43 days agoChange DetectedThe revision label on the page has been updated to v3.6.6, signaling a minor metadata update. This change does not alter the study details, eligibility criteria, or results presented on the page.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a new version of the page content.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, signaling a new page version. This is a maintenance update and does not change the study details, eligibility criteria, or results presented.SummaryDifference0.1%

- Check86 days agoChange DetectedThe disease terminology was updated by adding 'Steatotic Liver Disease' and removing 'Fatty Liver Disease' to reflect current nomenclature.SummaryDifference0.1%

Stay in the know with updates to Study of ARO-HSD in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of ARO-HSD in NASH Clinical Trial page.